SEE ATTACHED DOCUMENTS FOR INSTRUCTIONS AND TEMPLATE
DUE DATE JANUARY 3, 2025
NO PLAGIARISM ACCEPTED MORE THAN 10%, THIS ASSIGNMENT IS SUBMITTED BY TURNIN IN
DB 6 PATIENT CASE SCENARIO DEBATE
DIRECTIONS SCREEN SHOT IN SHARED FILES!!
WEEKLY READINGS:
- Goldin, D. S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing.
- Chapter 9, “Stimulants/Neurodevelopmental Disorders” (pp. 178–208)
- Chapter 10, “Antidementia” (pp. 208–227)
- Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
- Chapter 11, “Attention Deficit Hyperactivity Disorder and Its Treatment” (pp. 449–485)
- Chapter 12, “Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine” (pp. 486–537)
- American Academy of Pediatrics. (2019, October). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsLinks to an external site.. Pediatrics, 144(4), Article e20192528. https://doi.org/10.1542/peds.2019-2528
- Drugs.comLinks to an external site.. (2023). https://www.drugs.com/
Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc. - CHADD’s National Resource Center on ADHD. (2023). ADHD medications approved by the U.S. Food and Drug Administration: Stimulant medicationsLinks to an external site.. https://d393uh8gb46l22.cloudfront.net/wp-content/uploads/2020/02/ADHD-Medications-Approved-by-FDA-2.23.pdf
Note: Utilize this medication table resource to familiarize yourself with the medications aligned with the topics presented this week.